Sanofi reported EUR72.88B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -4.58B 1.35B Sep/2026
Aena EUR 9.72B 860.34M Sep/2026
Alcon AG USD 21.6B 538M Jun/2026
Almirall EUR 1.53B 43.26M Jun/2026
Amarin USD 444.41M 796K Sep/2026
Amgen USD 14.35B 2.66B Sep/2026
AstraZeneca USD 51.73B 1.43B Sep/2026
Bayer EUR 29.18B 533M Sep/2026
Biogen USD 19.04B 194.3M Sep/2026
BMW EUR 97.44B 2.11B Jun/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Eli Lilly USD 40.27B 6.39B Sep/2026
Essilor EUR 39.22B 329M Jun/2026
Fresenius EUR 20.51B 810M Sep/2026
Fresenius Medical Care EUR 13.76B 226.23M Sep/2026
Genmab DKK 5.96B 275M Jun/2026
Gilead Sciences USD 13.04B 1.3B Sep/2026
GlaxoSmithKline GBP 18.75B 1.11B Sep/2026
GRIFOLS EUR 5.79B 2.19B Sep/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
J&J USD 81.53B 3.44B Sep/2026
Lakefront Biotherapeutics EUR 3.26B 10.26M Jun/2026
Lonza CHF 9.13B 513M Dec/2025
Mercedes-Benz AG EUR 93.29B 1.52B Sep/2026
Merck EUR 31.34B 1.16B Sep/2026
Merck USD 44.89B 2.96B Sep/2026
Novartis USD 37.23B 4.72B Sep/2026
Novo Nordisk DKK 221.28B 18.21B Jun/2026
Orion EUR 1.4B 129.5M Sep/2026
Pfizer USD 89B 3.81B Sep/2026
Philips EUR 11.61B 133M Sep/2026
Recordati EUR 2.34B 209.24M Sep/2026
Regeneron Pharmaceuticals USD 33.5B 1.79B Sep/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 72.88B 3.31B Sep/2026
Sanofi EUR 69.57B 3.58B Jun/2026
SAP EUR 45.95B 1.2B Sep/2026
UCB EUR 10.87B 1.18B Dec/2025
Vinci EUR 30.59B 3.74B Jun/2026
Volkswagen EUR 176.16B 2.16B Mar/2026